Frontiers in Cellular and Infection Microbiology

Original Research

Published on 04 Jun 2024

Probiotic bacteria can modulate immune responses to paratuberculosis vaccination

in Microbial Vaccines

Maddi Oyanguren
Elena Molina
Maitane Mugica
Iraia Ladero-Auñon
Miguel Fuertes
Miguel Fernández
Julio Benavides
Natalia Elguezabal

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2024.1394070

5,035 views
6 citations

Original Research

Published on 04 Apr 2024

Second booster dose improves antibody neutralization against BA.1, BA.5 and BQ.1.1 in individuals previously immunized with CoronaVac plus BNT162B2 booster protocol

in Microbial Vaccines

Guilherme R. F. Campos
Nathalie Bonatti Franco Almeida
Priscilla Soares Filgueiras
Camila Amormino Corsini
Sarah Vieira Contin Gomes
Daniel Alvim Pena de Miranda
Jéssica Vieira de Assis
Thaís Bárbara de Souza Silva
Pedro Augusto Alves
Gabriel da Rocha Fernandes

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2024.1371695

3,777 views
3 citations

Review

Published on 03 Apr 2024

Swine influenza A virus: challenges and novel vaccine strategies

in Microbial Vaccines

Erika Petro-Turnquist
Matthew J. Pekarek
Eric A. Weaver

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2024.1336013

12,284 views
25 citations

Original Research

Published on 02 Apr 2024

A novel approach to designing viral precision vaccines applied to SARS-CoV-2

in Microbial Vaccines

Khaled Trabelsi
Noureddin Ben Khalaf
Ahmed R. Ramadan
Amany Elsharkawy
Dana Ashoor
Sadok Chlif
Thouraya Boussoffara
Melika Ben-Ahmed
Mukesh Kumar
M-Dahmani Fathallah

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2024.1346349

4,000 views
1 citation

Original Research

Published on 20 Mar 2024

TRAIL and IP-10 dynamics in pregnant women post COVID-19 vaccination: associations with neutralizing antibody potency

in Microbial Vaccines

Wei-Chun Chen
Shu-Yu Hu
Chao-Min Cheng
Ching-Fen Shen
Hui-Yu Chuang
Chin-Ru Ker
Der-Ji Sun
Ching-Ju Shen

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2024.1358967

3,388 views
1 citation

Original Research

Published on 28 Feb 2024

Vaccination with parasite-specific TcTASV proteins combined with recombinant baculovirus as a delivery platform protects against acute and chronic Trypanosoma cruzi infection

in Microbial Vaccines

Yamil E. Masip
Lucas D. Caeiro
Maximiliano Cosenza
Miriam Postan
Guido Molina
Oscar Taboga
María Paula Molinari
Valeria Tekiel

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2024.1297321

10,364 views
7 citations

Original Research

Published on 07 Feb 2024

Leveraging baseline transcriptional features and information from single-cell data to power the prediction of influenza vaccine response

in Microbial Vaccines

Xiangyu Ye
Sheng Yang
Junlan Tu
Lei Xu
Yifan Wang
Hongbo Chen
Rongbin Yu
Peng Huang

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2024.1243586

3,193 views
2 citations

Original Research

Published on 09 Jan 2024

Antibody reactive immunomes of Ehrlichia chaffeensis and E. canis are diverse and defined by conformational antigenic determinants

in Microbial Vaccines

Tian Luo
Jignesh G. Patel
Xiaofeng Zhang
Jere W. McBride

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2023.1321291

2,965 views
5 citations

Original Research

Published on 12 Dec 2023

Excessive daytime sleepiness is associated with impaired antibody response to influenza vaccination in older male adults

in Microbial Vaccines

Huy Quang Quach
Nathaniel D. Warner
Inna G. Ovsyannikova
Naima Covassin
Gregory A. Poland
Virend K. Somers
Richard B. Kennedy

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2023.1229035

4,033 views
5 citations

Review

Published on 05 Dec 2023

Salmonella enterica and outer membrane vesicles are current and future options for cancer treatment

in Microbial Vaccines

Genesy Pérez Jorge
Marco Túlio Pardini Gontijo
Marcelo Brocchi

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2023.1293351

8,600 views
11 citations

Original Research

Published on 15 Nov 2023

Immunization with different recombinant West Nile virus envelope proteins induces varying levels of serological cross-reactivity and protection from infection

in Microbial Vaccines

Rebecca Weiß
Leila Issmail
Alexandra Rockstroh
Thomas Grunwald
Jasmin Fertey
Sebastian Ulbert

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2023.1279147

4,364 views
11 citations

Review

Published on 15 Nov 2023

Multiplexed suspension array immunoassays for detection of antibodies to pneumococcal polysaccharide and conjugate vaccines

in Microbial Vaccines

Sherry A. Dunbar

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2023.1296665

4,051 views
9 citations

Original Research

Published on 26 Oct 2023

Engineering a dual vaccine against COVID-19 and tuberculosis

in Microbial Vaccines

Carlyn Monèt Guthrie
Xuejuan Tan
Amber Cherry Meeker
Ashton Elisabeth Self
Lin Liu
Yong Cheng

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2023.1273019

3,541 views
4 citations

Original Research

Published on 19 Oct 2023

Integrated genomic analysis of antibiotic resistance and virulence determinants in invasive strains of Streptococcus pneumoniae

in Microbial Vaccines

Lin Liu
Yanfei Wang
Lihong Ge
Dongping Hu
Xi Xiang
Ying Fu
Jun Lu
Xi Li
Yunsong Yu
Yuexing Tu

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2023.1238693

5,033 views
4 citations

Review

Published on 20 Sep 2023

Pilus of Streptococcus pneumoniae: structure, function and vaccine potential

in Microbial Vaccines

Chenglin Miao
Yali Cui
Ziyi Yan
Yongmei Jiang

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2023.1270848

9,549 views
10 citations

Original Research

Published on 05 Sep 2023

The instantly blocking-based fluorescent immunochromatographic assay for the detection of SARS-CoV-2 neutralizing antibody

in Microbial Vaccines

Yizhe Li
Jinyong He
Ying Zhang
Dan Liang
Jiaqi Zhang
Ruili Ji
Yue Wu
Zejie Su
Changwen Ke
Ning Xu

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2023.1203625

3,982 views
1 citation

Correction

Published on 24 Aug 2023

Corrigendum: A neutralizing bispecific single-chain antibody against SARS-CoV-2 Omicron variant produced based on CR3022

in Microbial Vaccines

Kaikai Yu
Bin Liu
Haotian Yu
Chengbiao Sun
Xuefeng Wang
Guorui Li
Mingxin Dong
Yan Wang
Jianxu Zhang
Na Xu

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2023.1264974

1,595 views
1 citation

Brief Research Report

Published on 21 Aug 2023

Vaccination with the Crimean-Congo hemorrhagic fever virus viral replicon vaccine induces NP-based T-cell activation and antibodies possessing Fc-mediated effector functions

in Microbial Vaccines

F. E. M. Scholte
E. Karaaslan
T. J. O’Neal
T. E. Sorvillo
S. C. Genzer
S. R. Welch
J. D. Coleman-McCray
J. R. Spengler
M. H. Kainulainen
J. M. Montgomery

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2023.1233148

10,874 views
19 citations

Original Research

Published on 16 May 2023

Nasal immunization with H7 flagellin protects mice against hemolytic uremic syndrome secondary to Escherichia coli O157:H7 gastrointestinal infection

in Microbial Vaccines

Alan Mauro Bernal
Fernando Nicolás Sosa
María Florencia Todero
Daniela Romina Montagna
Mónica Elba Vermeulen
Romina Jimena Fernández-Brando
María Victoria Ramos
Agustina Juliana Errea
Martin Rumbo
Marina Sandra Palermo

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2023.1143918

3,703 views
3 citations

Original Research

Published on 03 May 2023

A neutralizing bispecific single-chain antibody against SARS-CoV-2 Omicron variant produced based on CR3022

in Microbial Vaccines

Kaikai Yu
Bin Liu
Haotian Yu
Chengbiao Sun
Xuefeng Wang
Guorui Li
Mingxin Dong
Yan Wang
Jianxu Zhang
Na Xu

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2023.1155293

3,974 views
6 citations

Original Research

Published on 25 Apr 2023

Characterization of fliR-deletion mutant ΔfliR from Vibrio alginolyticus and the evaluation as a live attenuated vaccine

in Microbial Vaccines

Fan Da
Xiaoju Wan
Guixiang Lin
Jichang Jian
Shuanghu Cai

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2023.1162299

2,837 views
11 citations

Original Research

Published on 12 Apr 2023

Human adenovirus type 7 subunit vaccine induces dendritic cell maturation through the TLR4/NF-κB pathway is highly immunogenic

in Microbial Vaccines

Yaru Li
Xia Yang
Renshuang Zhao
Zhiru Xiu
Shanzhi Li
Yue Li
Gaojie Song
Chenchen Ge
Jinbo Fang
Jicheng Han

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2023.1117230

3,817 views
3 citations

Original Research

Published on 30 Mar 2023

Evaluation of Mycobacterium avium subsp. paratuberculosis isocitrate lyase (IcL) and ABC transporter (BacA) knockout mutants as vaccine candidates

in Microbial Vaccines

Razieh Eshraghisamani
Rakel Arrazuria
Lucy Luo
Jeroen De Buck

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2023.1149419

6,673 views
9 citations

Original Research

Published on 21 Mar 2023

Construction and evaluation of DNA vaccine encoding Crimean Congo hemorrhagic fever virus nucleocapsid protein, glycoprotein N-terminal and C-terminal fused with LAMP1

in Microbial Vaccines

Yong-Liang Hu
Lian-Qing Zhang
Xiao-Qian Liu
Wei Ye
Yue-Xi Zhao
Liang Zhang
Zun-Xian Qiang
Lin-Xuan Zhang
Ying-Feng Lei
Dong-Bo Jiang

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2023.1121163

6,482 views
17 citations

48 articles

articles

Probiotic bacteria can modulate immune responses to paratuberculosis vaccination

Second booster dose improves antibody neutralization against BA.1, BA.5 and BQ.1.1 in individuals previously immunized with CoronaVac plus BNT162B2 booster protocol

Swine influenza A virus: challenges and novel vaccine strategies

A novel approach to designing viral precision vaccines applied to SARS-CoV-2

TRAIL and IP-10 dynamics in pregnant women post COVID-19 vaccination: associations with neutralizing antibody potency

Vaccination with parasite-specific TcTASV proteins combined with recombinant baculovirus as a delivery platform protects against acute and chronic Trypanosoma cruzi infection

Leveraging baseline transcriptional features and information from single-cell data to power the prediction of influenza vaccine response

Antibody reactive immunomes of Ehrlichia chaffeensis and E. canis are diverse and defined by conformational antigenic determinants

Excessive daytime sleepiness is associated with impaired antibody response to influenza vaccination in older male adults

Salmonella enterica and outer membrane vesicles are current and future options for cancer treatment

Immunization with different recombinant West Nile virus envelope proteins induces varying levels of serological cross-reactivity and protection from infection

Multiplexed suspension array immunoassays for detection of antibodies to pneumococcal polysaccharide and conjugate vaccines

Engineering a dual vaccine against COVID-19 and tuberculosis

Integrated genomic analysis of antibiotic resistance and virulence determinants in invasive strains of Streptococcus pneumoniae

Pilus of Streptococcus pneumoniae: structure, function and vaccine potential

The instantly blocking-based fluorescent immunochromatographic assay for the detection of SARS-CoV-2 neutralizing antibody

Corrigendum: A neutralizing bispecific single-chain antibody against SARS-CoV-2 Omicron variant produced based on CR3022

Vaccination with the Crimean-Congo hemorrhagic fever virus viral replicon vaccine induces NP-based T-cell activation and antibodies possessing Fc-mediated effector functions

Nasal immunization with H7 flagellin protects mice against hemolytic uremic syndrome secondary to Escherichia coli O157:H7 gastrointestinal infection

A neutralizing bispecific single-chain antibody against SARS-CoV-2 Omicron variant produced based on CR3022

Characterization of fliR-deletion mutant ΔfliR from Vibrio alginolyticus and the evaluation as a live attenuated vaccine

Human adenovirus type 7 subunit vaccine induces dendritic cell maturation through the TLR4/NF-κB pathway is highly immunogenic

Evaluation of Mycobacterium avium subsp. paratuberculosis isocitrate lyase (IcL) and ABC transporter (BacA) knockout mutants as vaccine candidates

Construction and evaluation of DNA vaccine encoding Crimean Congo hemorrhagic fever virus nucleocapsid protein, glycoprotein N-terminal and C-terminal fused with LAMP1